Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1696 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

China Biologic Products Q4 Revenues Up

Gross profit increased 208.6% year-over-year to $27.3m, representing a gross margin of 72.7% as compared to 67.2% a year ago. The gross profit and margin increases were primarily

Arena Pharma Begins APD916 Phase 1 Trial

Arena Pharma said that APD916 was efficacious in multiple preclinical models, and the data suggest that it has potential utility in the treatment of narcolepsy with or without